Stay updated on Olaparib in BRCA Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the Olaparib in BRCA Ovarian Cancer Clinical Trial page.

Latest updates to the Olaparib in BRCA Ovarian Cancer Clinical Trial page
- Check3 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedThe page’s footer revision/version indicator was updated from **v3.5.2** to **v3.5.3**.SummaryDifference0.0%

- Check25 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check39 days agoChange DetectedPadova, Italy was added to the locations list and Padua, Italy was removed.SummaryDifference0.0%

- Check54 days agoChange DetectedNapoli, Italy was replaced with Naples, Italy and the Naples site was added to the study locations. The page revision updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check68 days agoChange DetectedRevision label updated from v3.4.2 to v3.4.3. This appears to be an internal version update not affecting study content or user-facing features.SummaryDifference0.0%

- Check89 days agoChange DetectedThe revision label was updated from v3.4.1 to v3.4.2. No core content or functionality of the study page appears to be affected.SummaryDifference0.0%

Stay in the know with updates to Olaparib in BRCA Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Olaparib in BRCA Ovarian Cancer Clinical Trial page.